🔗 Share this article

The Nobel Prize in Physiology or Medicine has been granted for transformative discoveries that illuminate how the body's defense network targets dangerous infections while sparing the body's own cells.

A trio of esteemed scientists—Japan's Shimon Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—received this accolade.

Their research uncovered unique "sentinels" within the immune system that eliminate malfunctioning immune cells capable of harming the body.

These findings are now enabling new therapies for immune disorders and malignancies.

These winners will share a monetary award worth 11m SEK.

Decisive Findings

"Their research has been essential for comprehending how the body's defenses functions and the reason we do not all suffer from severe self-attack conditions," stated the head of the award panel.

The trio's research address a fundamental mystery: How does the defense system defend us from numerous infections while leaving our healthy cells unharmed?

Our immune system uses white blood cells that search for indicators of infection, even viruses and germs it has never encountered.

These cells utilize sensors—known as recognition units—that are generated by chance in a vast number of variations.

That gives the immune system the capacity to combat a wide array of invaders, but the randomness of the process unavoidably creates white blood cells that can attack the host.

Protectors of the Immune System

Researchers earlier understood that some of these problematic white blood cells were destroyed in the immune organ—where white blood cells develop.

The latest award recognizes the discovery of regulatory T-cells—known as the immune system's "security guards"—which patrol the body to neutralize other immune cells that attack the healthy cells.

It is known that this process fails in autoimmune diseases such as type-1 diabetes, MS, and rheumatoid arthritis.

The prize committee added, "These findings have laid the foundation for a new field of investigation and accelerated the development of innovative therapies, for instance for tumors and immune disorders."

In cancer, regulatory T-cells prevent the body from fighting the growth, so research are aimed at reducing their quantity.

For self-attack disorders, experiments are exploring boosting T-reg cells so the organism is not being harmed. A similar approach could also be effective in minimizing the risks of organ transplant failure.

Innovative Studies

Professor Sakaguchi, from Osaka University, conducted experiments on rodents that had their immune gland removed, causing self-attack conditions.

He showed that introducing immune cells from healthy animals could stop the illness—suggesting there was a system for blocking immune cells from attacking the body.

Mary Brunkow, affiliated with the Institute for Systems Biology in a US city, and Fred Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were investigating an genetic immune disorder in rodents and humans that led to the discovery of a genetic factor vital for how regulatory T-cells function.

"The groundbreaking research has uncovered how the immune system is kept in check by regulatory T cells, stopping it from accidentally attacking the body's own tissues," commented a leading physiology expert.

"This research is a remarkable illustration of how basic physiological research can have broad consequences for human health."